Recent Finacing
Recent Raise
Arthex is a preclinical-stage biotech developing antisense antimiR therapies targeting miRNAs for Myotonic Dystrophy Type 1, advancing optimized candidates through preclinical and regulatory studies from Valencia.
Recent Investors
Total Raised
Funding round
Investors